{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:45:56Z","timestamp":1762112756429},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":353,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J of Neuroscience"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The centrally acting aromatic amino acid dopa decarboxylase (AADC) inhibitor, 3\u2010hydroxybenzyl hydrazine (NSD\u20101015), is widely used to study the neurotransmitter\u2010like actions of <jats:sc>l<\/jats:sc>\u2010DOPA. However, the effects of NSD\u20101015 on <jats:sc>l<\/jats:sc>\u2010<jats:sc>DOPA<\/jats:sc>\u2010induced motor activity are unclear as both increases and decreases have been reported. We now investigate the effects of NSD\u20101015 on <jats:sc>l<\/jats:sc>\u2010DOPA\u2010induced contralateral circling behaviour in 6\u2010OHDA\u2010lesioned rats and on striatal levels of <jats:sc>l<\/jats:sc>\u2010DOPA, 3\u2010O\u2010methyl\u2010DOPA (3\u2010OMD), dopamine, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) using microdialysis techniques. NSD\u20101015 (50\u2013200\u2003mg\/kg i.p.) inhibited AADC activity both in the liver and striatum of normal rats. Administration of NSD\u20101015 (50\u2013200\u2003mg\/kg i.p.), delayed the onset of circling produced by administration of <jats:sc>l<\/jats:sc>\u2010DOPA (25\u2003mg\/kg i.p.) and carbidopa (12.5\u2003mg\/kg i.p.), suggesting blockade of central AADC activity. However, the duration of the <jats:sc>l<\/jats:sc>\u2010DOPA\u2010induced circling was prolonged and overall no inhibition of circling behaviour occurred. <jats:sc>l<\/jats:sc>\u2010DOPA (25\u2003mg\/kg i.p.) plus carbidopa (12.5\u2003mg\/kg i.p.) increased extracellular levels of <jats:sc>l<\/jats:sc>\u2010DOPA, 3\u2010OMD, dopamine, DOPAC and HVA in the 6\u2010OHDA\u2010lesioned striatum. Pretreatment of rats with the central AADC inhibitor, NSD\u20101015 (100\u2003mg\/kg i.p.), potentiated the increase in dialysate levels of <jats:sc>l<\/jats:sc>\u2010DOPA and 3\u2010OMD. However, it did not reduce striatal dopamine levels in the 6\u2010OHDA\u2010lesioned hemisphere, which were elevated following <jats:sc>l<\/jats:sc>\u2010DOPA administration. The increases in DOPAC and HVA levels were abolished by NSD\u20101015 pretreatment. These results suggest that, while NSD\u20101015 blocks central AADC activity, it also acts as a monoamine oxidase inhibitor so maintaining striatal dopamine concentration by reducing dopamine metabolism. NSD\u20101015, therefore, may not be an appropriate tool for the study of brain AADC activity and for assessing the neuromodulatory role of <jats:sc>l<\/jats:sc>\u2010DOPA.<\/jats:p>","DOI":"10.1046\/j.0953-816x.2000.01370.x","type":"journal-article","created":{"date-parts":[[2003,3,6]],"date-time":"2003-03-06T14:35:05Z","timestamp":1046961305000},"page":"162-170","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The central aromatic amino acid DOPA decarboxylase inhibitor, NSD\u20101015, does not inhibit <scp>l<\/scp>\u2010DOPA\u2010induced circling in unilateral 6\u2010OHDA\u2010lesioned\u2010rats"],"prefix":"10.1111","volume":"13","author":[{"given":"Sarah A.","family":"Treseder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91318-B"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(91)90690-U"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91399-L"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244661"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01271567"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90050-Y"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90097-9"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(99)00406-6"},{"key":"e_1_2_7_10_1","first-page":"163","article-title":"Dopamine oxidation and its inhibition by (\u2010) \u2010deprenyl in man","volume":"16","author":"Glover V.","year":"1980","journal-title":"J. Neural Transm."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(76)90167-3"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb11139.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.53.47"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.52.174"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(91)90464-5"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90631-V"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07506.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb03503.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(80)90353-6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890210107"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90292-5"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90090-T"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.20.6385"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00998277"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.12.1566"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)61019-4"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(86)90079-0"},{"key":"e_1_2_7_28_1","first-page":"S154","article-title":"Nanomolar L\u2010dopa induces Ca2+\u2010dependent and tetrodotoxin\u2010sensitive release of glutamate from striata of conscious rat","volume":"65","author":"Misu Y.","year":"1995","journal-title":"J. Neurochem."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90415-8"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90126-X"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb09306.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90229-1"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90250-3"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00500765"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701675"},{"key":"e_1_2_7_36_1","volume-title":"The Rat Brain Stereotaxic Coordinates","author":"Paxinos G.","year":"1986"},{"key":"e_1_2_7_37_1","volume-title":"A Stereotaxic Atlas of the Rat Brain","author":"Pelligrino L.","year":"1979"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870030203"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1981.tb10829.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90270-2"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.12.1609"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/35.1.3025289"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703189"},{"key":"e_1_2_7_44_1","first-page":"315","volume-title":"6\u2010Hydroxydopamine and Catecholamine Neurons","author":"Ungerstedt U.","year":"1971"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(70)90187-3"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63010108.x"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90250-X"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90893-0"}],"container-title":["European Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0953-816x.2000.01370.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.0953-816x.2000.01370.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:27:55Z","timestamp":1696289275000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.0953-816x.2000.01370.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.0953-816x.2000.01370.x"],"URL":"https:\/\/doi.org\/10.1046\/j.0953-816x.2000.01370.x","archive":["Portico"],"relation":{},"ISSN":["0953-816X","1460-9568"],"issn-type":[{"value":"0953-816X","type":"print"},{"value":"1460-9568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}